A positive anti‑HBe (hepatitis B e antibody) indicates the immune system has produced antibodies to the e antigen. It generally reflects lower viral replication and reduced infectivity, often seen during recovery or after successful treatment. However, it does not guarantee complete clearance of hepatitis B; HBV DNA testing, HBsAg status, and liver function tests are needed to assess viral activity and guide management.

HBeAb positive means the immune system has produced antibody to hepatitis B e antigen (anti-HBe), usually indicating lower viral replication and reduced infectiousness after seroconversion. It often signals transition to an inactive carrier state or recovery, but doesn’t guarantee the virus is cleared—HBV DNA and liver tests are needed. Discuss results and follow-up monitoring with your healthcare provider.

HBeAg is the hepatitis B “e” antigen — a viral protein whose presence indicates active HBV replication and high infectiousness. HBeAb (anti‑HBe) is the antibody against that antigen; its appearance usually signals lower viral replication and reduced infectivity, often during recovery or successful treatment. Exceptions occur (precore/core mutants), so HBV DNA testing gives definitive replication status.

A positive HBsAg means active hepatitis B infection (acute or chronic). A negative HBeAg usually indicates lower viral replication and reduced infectivity, but can also occur with pre-core/core promoter mutants that retain high viral load. Further evaluation—HBV DNA level, liver enzymes, anti-HBe, and liver assessment—is needed to determine disease activity and treatment. See a specialist for monitoring and management.

If HBe is high (HBeAg positive or elevated), it indicates active hepatitis B virus replication and greater infectivity. It’s linked to higher viral load, possible raised liver enzymes, and increased risk of liver inflammation, fibrosis, cirrhosis, and hepatocellular carcinoma. Management includes regular monitoring (HBV DNA, ALT, fibrosis assessment) and consideration of antiviral treatment to reduce viral replication and transmission.

If a hepatitis E test is positive, confirm with repeat/confirmatory testing and check liver function. Most cases are mild—rest, fluids, avoid alcohol and hepatotoxic medicines, and monitor for jaundice or worsening symptoms. Pregnant women and immunocompromised patients may need hospital care and antiviral treatment. Follow up with liver tests until recovery and seek prompt medical advice for any deterioration.